The spread of several infectious diseases, such as influenza, Zika, and Ebola, is increasing research and development (R&D) efforts because of the growing popularity of mRNA technology in vaccine development. The market has been driven by the SARS-CoV-2 outbreak, which has increased demand for effective vaccines to prevent morbidity and mortality.